Imatinib 400mg
$100.00 (USD)
0 समीक्षा
प्रकाशित द्वारा Epclusa Cost
- स्थानPhilippines
- दर्जास्टॉक में
- टाइपनया
विवरण
Imatinib was developed by Novartis. It was first approved for marketing by the US Food and Drug Administration (FDA) on May 10, 2001, and then approved for marketing by the European Medicines Agency (EMA) on November 7, 2001. On March 9, it was approved for marketing by the Japan Pharmaceuticals and Medical Devices Agency (PMDA). It is marketed in the United States by Novartis under the trade name Gleevec.
https://www.medixocentre.com/gleevec-imatinib-cost
संबंधित उत्पाद
